The Effects on Growth of a Non-Routine Infant Formula
Not Applicable
Completed
- Conditions
- Growth
- Registration Number
- NCT00655720
- Lead Sponsor
- Mead Johnson Nutrition
- Brief Summary
A study to evaluate the growth and development of term infants fed either an extensively hydrolyzed formula with probiotics, a partially hydrolyzed formula with probiotics, or an extensively hydrolyzed formula without probiotics
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 293
Inclusion Criteria
- Term infant
- Solely formula fed
- 14 days of age
Exclusion Criteria
- History of underlying disease
- Evidence of formula intolerance
- Current illness
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Growth (weight) 106 days
- Secondary Outcome Measures
Name Time Method Tolerance 106 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain probiotic effects on infant growth in NCT00655720?
How do hydrolyzed formulas compare to standard infant formulas in growth outcomes?
Which biomarkers correlate with improved tolerance to hydrolyzed infant formulas?
What adverse events are associated with probiotic-enriched hydrolyzed formulas in term infants?
How does the extensively hydrolyzed formula in NCT00655720 compare to partially hydrolyzed formulas in clinical efficacy?